Knowledge, attitudes, and practices of pregnant women regarding COVID-19 vaccination in pregnancy in 7 low- and middle-income countries: An observational trial from the Global Network for Women and Children's Health Research.


Journal

BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741

Informations de publication

Date de publication:
11 2022
Historique:
revised: 11 04 2022
received: 30 12 2021
accepted: 15 05 2022
pubmed: 22 5 2022
medline: 19 10 2022
entrez: 21 5 2022
Statut: ppublish

Résumé

We sought to determine the knowledge, attitudes and practices of pregnant women regarding COVID-19 vaccination in pregnancy in seven low- and middle-income countries (LMIC). Prospective, observational, population-based study. Study areas in seven LMICs: Bangladesh, India, Pakistan, Guatemala, Democratic Republic of the Congo (DRC), Kenya and Zambia. Pregnant women in an ongoing registry. COVID-19 vaccine questionnaires were administered to pregnant women in the Global Network's Maternal Newborn Health Registry from February 2021 through November 2021 in face-to-face interviews. Knowledge, attitude and practice regarding vaccination during pregnancy; vaccination status. No women were vaccinated except for small proportions in India (12.9%) and Guatemala (5.5%). Overall, nearly half the women believed the COVID-19 vaccine is very/somewhat effective and a similar proportion believed that the COVID-19 vaccine is safe for pregnant women. With availability of vaccines, about 56.7% said they would get the vaccine and a 34.8% would refuse. Of those who would not get vaccinated, safety, fear of adverse effects, and lack of trust predicted vaccine refusal. Those with lower educational status were less willing to be vaccinated. Family members and health professionals were the most trusted source of information for vaccination. This COVID-19 vaccine survey in seven LMICs found that knowledge about the effectiveness and safety of the vaccine was generally low but varied. Concerns about vaccine safety and effectiveness among pregnant women is an important target for educational efforts to increase vaccination rates.

Identifiants

pubmed: 35596701
doi: 10.1111/1471-0528.17226
pmc: PMC9347929
doi:

Substances chimiques

COVID-19 Vaccines 0
Vaccines 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

2002-2009

Subventions

Organisme : NICHD NIH HHS
ID : UG1 HD076465
Pays : United States
Organisme : NICHD NIH HHS
ID : UG1 HD078439
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022 John Wiley & Sons Ltd.

Références

World Health Organization. WHO coronavirus (COVID-19) dashboard | WHO coronavirus (COVID-19) dashboard with vaccination data. [cited 12 November 2021]. Available from: https://covid19.who.int/
Lahiri A, Jha SS, Bhattacharya S, Ray S, Chakraborty A. Effectiveness of preventive measures against COVID-19: a systematic review of in silico modeling studies in Indian context. Indian J Pub Health. 2020;64:156.
Grannis SJ, Rowley EA, Ong TC, Stenehjem E, Klein NP, DeSilva MB, et al. Interim estimates of COVID-19 vaccine effectiveness against COVID-19-associated emergency department or urgent care clinic encounters and hospitalizations among adults during SARS-CoV-2 B.1.617.2 (Delta) variant predominance - nine states, June-August 2021. MMWR Morb Mortal Wkly Rep. 2021;70(37):1291-3.
Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020;586(7830):589-93.
Tartof SY, Slezak JM, Fischer H, Hong V, Ackerson BK, Ranasinghe ON, et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet. 2021;398(10309):1407-16.
Khan YH, Mallhi TH, Alotaibi NH, Alzarea AI, Alanazi AS, Tanveer N, et al. Threat of COVID-19 vaccine hesitancy in Pakistan: the need for measures to neutralize misleading narratives. Am J Trop Med Hyg. 2020;103(2):603-4.
Dudley MZ, Privor-Dumm L, Dubé È, MacDonald NE. Words matter: vaccine hesitancy, vaccine demand, vaccine confidence, herd immunity and mandatory vaccination. Vaccine. 2020;38:709-11.
Arce JSS, Warren SS, Meriggi NF, et al. COVID-19 vaccine acceptance and hesitancy in low and middle income countries, and implications for messaging. medRxiv. 2021.
CDC CfDaP. New CDC data: COVID-19 vaccination safe for pregnant people. Pregnancy and Vaccination | CDC; 2021 [cited 12 July 2021]. Available from: https://www.cdc.gov/vaccines/pregnancy/index.html
WHO. COVID-19 vaccines, safety of COVID-19 vaccines, vaccine efficacy, effectiveness and protection. 2021 [cited 01 June 2022]. Available from: https://extranet.who.int/pqweb/vaccines/covid-19-vaccines
Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, et al. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. New Eng J Med. 2021;384:2273-82.
CDC. COVID-19 vaccines while pregnant or breastfeeding. 2021 [cited 01 June 2022]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html
Skjefte M, Ngirbabul M, Akeju O, Escudero D, Hernandez-Diaz S, Wyszynski DF, et al. COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries. Eur J Epidemiol. 2021;36:197-211.
Omer SB, Yildirim I, Forman HP. Herd immunity and implications for SARS-CoV-2 control. JAMA. 2020;324:2095-6.
Januszek SM, Faryniak-Zuzak A, Barnaś E, Łoziński T, Góra T, Siwiec N, et al. The approach of pregnant women to vaccination based on a COVID-19 systematic review. Medicina. 2021;57:977.
El-Elimat T, AbuAlSamen MM, Almomani BA, Al-Sawalha NA, Alali FQ. Acceptance and attitudes toward COVID-19 vaccines: a cross-sectional study from Jordan. PLoS One. 2021;16:e0250555.
Battarbee AN, Stockwell MS, Varner M, Newes-Adeyi G, Daugherty M, Gyamfi-Bannerman C, et al. Attitudes toward COVID-19 illness and COVID-19 vaccination among pregnant women: a cross-sectional multicenter study during August-December 2020. Am J Perinatol. 2022;39:75-83.
Koso-Thomas M, McClure EM, Global Network for Women's and Children's Heatlh Research Investigators. The Global Network for Women's and Children's Health Research: a model of capacity-building research. Semin Fetal Neonatal Med. 2015;20(5):293-9.
McClure EM, Garces AL, Hibberd PL, Moore JL, Goudar SS, Saleem S, et al. The Global Network Maternal Newborn Health Registry: a multi-country, community-based registry of pregnancy outcomes. Reprod Health. 2020;17(Suppl 2):184.
Miranda KK, Mehl R, Costantine MM, Johnson A, Cohen J, Summerfield TL, Kiefer MK, et al. Characteristics and perceptions associated with COVID-19 vaccination hesitancy among pregnant and postpartum individuals: a cross-sectional study. BJOG. 2022. https://doi.org/10.1111/1471-0528.17110

Auteurs

Seemab Naqvi (S)

Aga Khan University, Karachi, Pakistan.

Sarah Saleem (S)

Aga Khan University, Karachi, Pakistan.

Farnaz Naqvi (F)

Aga Khan University, Karachi, Pakistan.

Sk Masum Billah (SM)

Maternal and Child Health Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
University of Virginia, Charlottesville, Virginia, USA.

Eleanor Nielsen (E)

RTI International, Durham, North Carolina, USA.

Elizabeth Fogleman (E)

RTI International, Durham, North Carolina, USA.

Nalini Peres-da-Silva (N)

RTI International, Durham, North Carolina, USA.

Lester Figueroa (L)

Instituto de Nutrición de Centroamérica y Panamá, Guatemala City, Guatemala.

Manolo Mazariegos (M)

Instituto de Nutrición de Centroamérica y Panamá, Guatemala City, Guatemala.

Ana L Garces (AL)

Instituto de Nutrición de Centroamérica y Panamá, Guatemala City, Guatemala.

Archana Patel (A)

Lata Medical Research Foundation, Nagpur, India.

Prabir Das (P)

Lata Medical Research Foundation, Nagpur, India.

Avinash Kavi (A)

KLE Academy Higher Education and Research, J N Medical College, Belagavi, India.

Shivaprasad S Goudar (SS)

KLE Academy Higher Education and Research, J N Medical College, Belagavi, India.

Fabian Esamai (F)

Moi University School of Medicine, Eldoret, Kenya.

Elwyn Chomba (E)

University Teaching Hospital, Lusaka, Zambia.

Adrien Lokangaka (A)

Department of Pediatrics, Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.

Antoinette Tshefu (A)

Department of Pediatrics, Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.

Rashidul Haque (R)

Maternal and Child Health Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.

Shahjahan Siraj (S)

Maternal and Child Health Division, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.

Sana Yousaf (S)

Aga Khan University, Karachi, Pakistan.

Melissa Bauserman (M)

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

Edward A Liechty (EA)

Department of Pediatrics, Indiana School of Medicine, University of Indiana, Indianapolis, Indiana, USA.

Nancy F Krebs (NF)

Section of Nutrition, Department of Pediatrics, University of Colorado School of Medicine, Denver, Colorado, USA.

Richard J Derman (RJ)

Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Waldemar A Carlo (WA)

University of Alabama at Birmingham, Birmingham, Alabama, USA.

William A Petri (WA)

University of Virginia, Charlottesville, Virginia, USA.

Patricia L Hibberd (PL)

Boston University School of Public Health, Boston, Massachusetts, USA.

Marion Koso-Thomas (M)

Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, Maryland, USA.

Vanessa Thorsten (V)

RTI International, Durham, North Carolina, USA.

Elizabeth M McClure (EM)

RTI International, Durham, North Carolina, USA.

Robert L Goldenberg (RL)

Department of Obstetrics and Gynecology, Columbia University School of Medicine, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH